Optimizing arginine deprivation for hard-to-treat cancers.
作者信息
Khadeir Ramsay, Szyszko Teresa, Szlosarek Peter W
机构信息
Peter W. Szlosarek: Center for Molecular Oncology, Barts Cancer Institute - a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, UK and Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.
出版信息
Oncotarget. 2017 Oct 27;8(57):96468-96469. doi: 10.18632/oncotarget.22099. eCollection 2017 Nov 14.
Abstract
摘要
相似文献
1
Optimizing arginine deprivation for hard-to-treat cancers.
Oncotarget. 2017 Oct 27;8(57):96468-96469. doi: 10.18632/oncotarget.22099. eCollection 2017 Nov 14.
2
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.
Int J Cancer. 2009 Sep 15;125(6):1454-63. doi: 10.1002/ijc.24546.
3
BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma.
Oncotarget. 2016 Apr 5;7(14):17665-80. doi: 10.18632/oncotarget.6882.
4
Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines.
Sci Rep. 2015 Apr 30;5:9783. doi: 10.1038/srep09783.
5
Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells.
Mol Pharm. 2016 Jan 4;13(1):262-71. doi: 10.1021/acs.molpharmaceut.5b00706. Epub 2015 Dec 17.
6
Targeting arginine metabolism pathway to treat arginine-dependent cancers.
Cancer Lett. 2015 Aug 1;364(1):1-7. doi: 10.1016/j.canlet.2015.04.020. Epub 2015 Apr 23.
7
Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes.
Cell Biol Int. 2010 Nov;34(11):1085-9. doi: 10.1042/CBI20100451.
8
Cyclic adenosine monophosphate-induced argininosuccinate synthase 1 expression is essential during mouse decidualization.
Mol Cell Endocrinol. 2014 May 5;388(1-2):20-31. doi: 10.1016/j.mce.2014.02.005. Epub 2014 Feb 18.
9
Arginine deprivation in cancer therapy.
Curr Opin Clin Nutr Metab Care. 2015 Jan;18(1):78-82. doi: 10.1097/MCO.0000000000000122.
10
Integrity and stability of the citrulline-arginine pathway in normal and tumour cell lines.
Cancer Lett. 2005 Sep 28;227(2):141-52. doi: 10.1016/j.canlet.2005.01.004.
引用本文的文献
1
Spermine accumulation via spermine synthase promotes tumor cell proliferation in head and neck squamous cell carcinoma.
BMC Cancer. 2025 Mar 5;25(1):402. doi: 10.1186/s12885-025-13820-x.
2
Arginine Signaling and Cancer Metabolism.
Cancers (Basel). 2021 Jul 15;13(14):3541. doi: 10.3390/cancers13143541.
3
Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy.
Theranostics. 2021 Jan 25;11(8):3624-3641. doi: 10.7150/thno.51795. eCollection 2021.
4
Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming.
Cell Death Dis. 2020 Aug 20;11(8):662. doi: 10.1038/s41419-020-02899-8.
5
New aspects of amino acid metabolism in cancer.
Br J Cancer. 2020 Jan;122(2):150-156. doi: 10.1038/s41416-019-0620-5. Epub 2019 Dec 10.
6
Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism.
Theranostics. 2018 Aug 10;8(16):4520-4534. doi: 10.7150/thno.25130. eCollection 2018.
本文引用的文献
1
Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers.
J Clin Oncol. 2017 Jun 1;35(16):1778-1785. doi: 10.1200/JCO.2016.71.3230. Epub 2017 Apr 7.
2
Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers.
Cell Rep. 2017 Jan 24;18(4):991-1004. doi: 10.1016/j.celrep.2016.12.077.
3
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial.
JAMA Oncol. 2017 Jan 1;3(1):58-66. doi: 10.1001/jamaoncol.2016.3049.
4
Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis.
Nature. 2015 Nov 19;527(7578):379-383. doi: 10.1038/nature15529. Epub 2015 Nov 11.
5
Argininosuccinate synthetase 1 depletion produces a metabolic state conducive to herpes simplex virus 1 infection.
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):E5006-15. doi: 10.1073/pnas.1321305110. Epub 2013 Dec 2.
6
Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.
Cancer Res. 2014 Feb 1;74(3):896-907. doi: 10.1158/0008-5472.CAN-13-1702. Epub 2013 Nov 27.
7
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma.
Cell Death Dis. 2013 Jan 17;4(1):e458. doi: 10.1038/cddis.2012.197.
8
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.
Int J Cancer. 2010 Jun 15;126(12):2762-72. doi: 10.1002/ijc.25202.
Zotero 插件